Investigating how cholesterol metabolism in skin cells can help treat inflammatory skin diseases
Targeting keratinocyte cholesterol metabolism to reveal novel mechanisms for treating inflammatory skin disease
This study is looking at how cholesterol affects skin cells and causes inflammation, which can lead to skin issues like acne rosacea, and it aims to find new ways to lower cholesterol in these cells to help improve treatments for these conditions.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10909785 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of cholesterol metabolism in skin cells, particularly keratinocytes, and how it relates to inflammation in various skin diseases. The researchers are exploring the mechanisms by which excess cholesterol can trigger inflammatory responses, which may lead to better-targeted therapies for conditions like acne rosacea and other chronic skin disorders. By using a novel synthetic high-density lipoprotein-like nanoparticle, the study aims to manipulate cholesterol levels in skin cells to reduce inflammation and improve treatment outcomes. This approach could provide insights into shared and unique pathways of inflammation in the skin.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with chronic inflammatory skin conditions such as acne rosacea or other dermatoses.
Not a fit: Patients with non-inflammatory skin conditions or those not affected by cholesterol metabolism may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer treatments for patients suffering from inflammatory skin diseases.
How similar studies have performed: Previous research has shown promising results in targeting cholesterol metabolism for treating inflammation, suggesting that this approach may be effective.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Trujillo, Jacquelyn — Northwestern University at Chicago
- Study coordinator: Trujillo, Jacquelyn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.